Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Douglass EA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Farokhnia M; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore and Bethesda, MD, USA.; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Rentsch CT; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK., Chuong V; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore and Bethesda, MD, USA.; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., McGinn MA; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Elvig SK; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Douglass EA; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Gonzalez LA; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Sanfilippo JE; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore and Bethesda, MD, USA., Marchette RCN; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Tunstall BJ; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.; Department of Pharmacology, Addiction Science, and Toxicology, University of Tennessee Health Science Center, Memphis, TN, USA., Fiellin DA; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA., Koob GF; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Justice AC; VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA.; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.; Center for Interdisciplinary Research on AIDS, Yale School of Public Health, New Haven, CT, USA., Leggio L; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Baltimore and Bethesda, MD, USA. lorenzo.leggio@nih.gov.; Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA. lorenzo.leggio@nih.gov.; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA. lorenzo.leggio@nih.gov.; Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. lorenzo.leggio@nih.gov.; Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA. lorenzo.leggio@nih.gov., Vendruscolo LF; Neurobiology of Addiction Section, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA. leandro.vendruscolo@nih.gov.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2022 Nov; Vol. 27 (11), pp. 4642-4652. Date of Electronic Publication: 2022 Sep 20.
Autor:
Zhu M; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.; Neuroscience Curriculum, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Echeveste Sanchez M; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Douglass EA; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Jahad JV; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Hanback TD; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Guhr Lee TN; Division of Pediatric Pulmonology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.; Marsico Lung Institute/Cystic Fibrosis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Esther CR Jr; Division of Pediatric Pulmonology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.; Marsico Lung Institute/Cystic Fibrosis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599., Cole M; Animal Models Core, The Scripps Research Institute, La Jolla, CA 92037., Roberts AJ; Animal Models Core, The Scripps Research Institute, La Jolla, CA 92037., Herman MA; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 melissa_herman@unc.edu.; Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Publikováno v:
ENeuro [eNeuro] 2021 Aug 11; Vol. 8 (4). Date of Electronic Publication: 2021 Aug 11 (Print Publication: 2021).